Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calender
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Tri-Conference
    • Next Generation Dx
    • Dx Innovation Summit
  • About
    • Editorial Profile
    • Editorial Calender
    • Contact
  • Molecular Med Tri-Conference
 
  • Ultra-Absorptive Nanofiber Swabs, Algorithm Predicts Blood Clot Risk, Melatonin Production as Prognostic Biomarker: COVID-19 Updates

    Diagnostics World News I New diagnostic assay allows testing and genomic surveillance simultaneously, a portable and bifunctional electrical detector for SARS-CoV-2, 1 in 3 infected asymptomatic. Plus: Melatonin produced in lungs could be used as a prognostic biomarker and machine learning predicts COVID-19 patient outcomes.

    Jan 29, 2021
  • Saliva-Based Lung Cancer Dx, Fingerstick Diagnostics, More

    Diagnostics World News | Saliva for early lunch cancer detection, new guidelines for diagnosis of bleeding disorder, Babson claims fingerstick diagnostics in a retail setting, and looking at Alzheimer’s. Plus: companion diagnostic agreements, and genomic sequencing for prenatal testing.

    Jan 28, 2021
  • New Scoring System For Aggressive Prostate Cancers

    Diagnostics World News | Moffitt Cancer Center researchers have discovered a way to pinpoint a subset of prostate cancer patients with aggressive tumors who may benefit from combined immune-radiotherapy modalities. The answer gets computed from a combination of the immune content score (ICS) and the 22-gene Decipher classifier score that is predictive of metastasis.

    Jan 25, 2021
  • Testing Strategies to Distinguish Between COVID-19 and Flu, Mitochondria Warns Of Severe Disease: COVID-19 Updates

    Diagnostics World News | Quantified smell loss the best predictor of COVID-19 among those with symptoms, the outlook for self-tests, circulating mitochondria as a warning of severe disease, and more. Plus: QIAGEN’s PCR test stands up to new variants, new development on tests to distinguish between SARS-CoV-2 and influenza.

    Jan 22, 2021
  • «
  • 111 (current)
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy